more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$248.91 USD

-5.62 (-2.21%)

Updated Jun 4, 2024 04:00 PM ET

After-Market: $245.86 -3.05 (-1.23%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.08%
2	Buy	17.91%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.55%
S&P	500	11.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

Bottom 34% (164 out of 249)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.

Abiomed (ABMD) at 52-Week High: What's Driving the Stock?

by Zacks Equity Research Published on June 06,2017

Share price of Abiomed, Inc. (ABMD), scaled a new 52-week high of $142.95 on Jun 5, eventually closing a bit lower at $141.81.

Edwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval

by Zacks Equity Research Published on June 06,2017

Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).

Tenet Healthcare Prices New Notes to Repay Existing Debts

by Zacks Equity Research Published on June 06,2017

Tenet Healthcare Corporation (THC) recently priced the previously announced private offering of newly issued notes.

QIAGEN Strengthens Cancer Research Foothold on New License

by Zacks Equity Research Published on June 06,2017

QIAGEN N.V. (QGEN) has received a worldwide license for biomarkers to be used in identifying patients who may have benefited from immune-oncology (I-O) therapies in cancer treatment.

Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive

by Zacks Equity Research Published on June 05,2017

Myriad Genetics, Inc. (MYGN), a leading molecular diagnostics and personalized medicine company recently unveiled positive data pertaining to its BRACAnalysis CDx test.

Align Sets Up Manufacturing Center in China, Grows in APAC

by Zacks Equity Research Published on June 05,2017

Align Technology (ALGN) has recently inaugurated a new Invisalign treatment planning facility in Chengdu, China.

Abbott Laboratories at 52-Week High on Product Line, Buyouts

by Zacks Equity Research Published on June 05,2017

Share price of IL-based Abbott Laboratories (ABT) scaled a new 52-week high of $46.55 on Jun 2, eventually closing a bit lower at $46.50.

QIAGEN & Bristol-Myers Squibb Partner on Cancer Research

by Zacks Equity Research Published on June 05,2017

QIAGEN N.V. (QGEN) has made significant advancement in the field of cancer research through the use of its revolutionary next-generation sequencing (NGS) technology.

Five Stocks Rocketing Higher on Huge Momentum

by David Bartosiak Published on June 01,2017

The bears were sent running, screaming towards their caves today as the market started strong and didn???t look back at all

Align Technology Upgrades iTero Element Intraoral Scanners

by Zacks Equity Research Published on June 01,2017

Based in California, leading dental product maker Align Technology, Inc. (ALGN) recently announced a software upgrade to its iTero Element intraoral scanners.

UnitedHealth Unit Taps Connecticut Orthopedic Surgery Market

by Zacks Equity Research Published on June 01,2017

Surgical Care Affiliates, Inc, a part of UnitedHealth Group's Optum unit, recently partnered with Western Connecticut Orthopedic Surgery Center by making an equity investment in the latter.

Why WellCare (WCG) Stock Should Be in Your Portfolio Now

by Zacks Equity Research Published on May 29,2017

Leading managed care company WellCare Health Plans, Inc.'s (WCG) business strategies should continue to support growth.

Align Technology Rises with Invisalign, SmartTrack Patents

by Zacks Equity Research Published on May 25,2017

Align Technology (ALGN) has received two U.S. Patents from the United States Patent and Trademark Office (USPTO) for its SmartTrack clear aligner material.